Raymond James analyst Lawrence Keusch reiterated an Outperform rating on Haemonetics (NYSE: HAE) after meeting with Bill Burke, CFO, at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE